Increased IFN-α activity is an important contributor to SLE pathogenesis because of its involvement in the induction of B-lymphocyte stimulator (BLyS) and DNA- and RNA- protein binding autoantibody specificities. This evidence concerns the gene IFNA1 and systemic lupus erythematosus.